GHTC joined civil society in urging G20 policymakers at today’s C20 meeting with the G20 Health Working Group to strengthen R&D to meet urgent health challenges, including achieving universal health coverage and combating antimicrobial resistance and other health threats.
Learn More
GHTC joined the humanitarian and development coalition InterAction in calling on G7 foreign ministers to prioritize health on the 2020 G7 agenda. The coalition released a policy report, including a section on health co-authored by GHTC, which urges the G7 to investment in R&D for new health tools.
PDF
GHTC submitted written testimony to key House appropriations subcommittees urging them to sustain and protect global health R&D funding in the fiscal year 2021 (FY21) budget.
Learn More
GHTC sent letters to the relevant appropriations subcommittees in the House and Senate asking them to sustain and protect global health R&D funding in the fiscal year 2021 (FY21) budget.
Learn More
GHTC director Jamie Bay Nishi delivered in-person testimony on March 12 before the House Appropriations Subcommittee on State, Foreign Operations, and Related Programs on the fiscal year 2021 budget for Global Health Programs at the US Agency for International Development and State Department.
Learn More
GHTC's US Policy Officer Emily Conron spoke with Healio Infectious Disease News about the disastrous impact the President's proposed budget cuts could have on global health R&D.
View
Devex featured an op-ed from GHTC's Director Jamie Bay Nishi making a case that to achieve healthy lives for all, we need a "one-two punch" of innovation and access.
View
GHTC condemns President Trump’s fiscal year 2021 budget request seeking deep cuts to global health and medical research programs. The budget proposes a 34 percent cut to global health programs at the US Agency for International Development and the State Department, as well as significant cuts to public health and research agencies within the Department of Health and Human Services.
Learn More